Background: Myocardial infarction (MI) often results in permanent
cardiac tissue necrosis and reduced heart functionality. Even with heart
disease being the number one cause of death in the US, there are
currently no effective methods of fully regenerating heart muscle
post-myocardial infarction. Mesenchymal stem cells (MSCs) are a
promising therapeutic option given their multi-potent nature and low
host immune reaction. Bioengineered polymeric nanofiber scaffolds
provide a structured growing environment and encourage cell elongation.
Overview: This study characterizes MSC biology on poly-ε-caprolactone
(PCL) nanofiber scaffolds in order to establish electrospun PCL
nanofibers as a working biological scaffold for MSC growth, and to
exhibit potential for further exploration of PCL nanofiber-grown MSC
implants as a treatment for MI. Methods: MSCs were seeded on PCL
scaffolds; cell viability was analyzed via XTT, cell apoptosis was
analyzed via TUNEL/DAPI staining, and differentiation markers were
analyzed via RT-PCR. Results: TUNEL/DAPI staining of confluent MSCs on
PCL scaffolds showed low cell apoptosis over time. RT-PCR results showed
no amplification of CD40 expression. Conclusion: PCL nanofibers seem to
provide a suitable microenvironment for MSC seeding and proliferation.
Further Direction: RT-PCR for CD80, CD86, COL1A1 (collagen), aSMA/Acta2
(smooth muscle), Flk1/VEGF2 (endothelial), Sparc (Osteonectin,
osteogenic), Adipoq (Adiponectin, adipogenic), Agre-cano (chondrogenic).